Book a Meeting

BetterBet™ Anti-IL23 On-Target Antibody (CAT#: AES-0622-ZP707) Datasheet

Target
IL23
Description
Anti-IL23 antibody takes advantage of the enrichment of some small molecules such as ATP in the tumor microenvironment, and activates the antibody by using the small molecule as a medium, so that the antibody is specifically activated only in the tumor.
Applications
"On-target" tumor antigen binding
Technology
ATP-mediated antibody engineering technology

Cooperation Seeking

Creative Biolabs is interested in collaborating with potential partners (include but not limit to major pharma or biotech firms) to further co-develop ADCC-enhanced IL23 antibody. For commercial partners interested in our ADCC-enhanced therapeutic antibodies, Creative Biolabs welcomes collaboration. Here are two ways for your choice, and please contact us for more details.
1) Collaborate with us and co-develop the programs from discovery phase to IND enabling. Costs will be shared.
2) Become a licensed candidate of our programs.
Looking forward to cooperating with you in the near future.
Official Name
interleukin 23 subunit alpha
Background
P19; SGRF; IL-23; IL-23A; IL23P19
Description
Anti-IL23 antibody takes advantage of the enrichment of some small molecules such as ATP in the tumor microenvironment, and activates the antibody by using the small molecule as a medium, so that the antibody is specifically activated only in the tumor.

In the tumor microenvironment, ATP is released from necrotic, apoptotic and other tumor cells, so its concentration is higher than that of normal cells. On-Target Antibody takes advantage of the enrichment of ATP in the tumor microenvironment to activate the antibody with ATP as a medium, so that the antibody is specifically activated only in the tumor.

Related Products

BetterBet™ Anti-IL23 FcγRIIB Binding Enhanced Antibody (CAT#: AES-0622-ZP379)
BetterBet™ Anti-IL23 Recycling Antibody (CAT#: AES-0622-ZP51)
Highly Galactosylated Anti-IL23 (Tildrakizumab) Antibody (CAT#: BioBet-GA-014ZP)
BetterBet™ Anti-IL23 Half-Life Extended Antibody (CAT#: AES-0622-ZP1035)
Non-fucosylated Anti-Human IL23 (Tildrakizumab) Therapeutic Antibody (CAT#: BioBet-014ZP)

All products and services are for Research Use Only. Do Not use in humans.

ONLINE INQUIRY

Creative Biolabs has established a team of customer support scientists ready to discuss ADCC/CDC optimization strategies, antibody production, bioinformatics analysis and other molecular biology/biotechnology issues.

  • *
  • *
  • *
USA

UK

Germany

ISO 9001 Certified - Creative Biolabs Quality Management System.